Reported covered position: Chief of Staff for Rep. Earl Pomeroy
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. H.R.10571, Surge to Save Newborns Act. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Support of reauthorization of priority review voucher program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
MOHAWK INDUSTRIES, INC. via ALSTON & BIRD LLP
2026 · first_quarter · 1A
Trade matters affecting the flooring and construction industry.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office
USAGAINSTALZHEIMER'S ACTION via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Source: Senate LDA
| MICCOSUKEE TRIBE OF INDIANS OF FLORIDA |
| 39 |
| 2013–2023 |
| FAIRVIEW HEALTH SERVICES | 37 | 2015–2024 |
| AETNA, INC. | 34 | 2011–2019 |
| CVS HEALTH | 33 | 2019–2026 |
| HEALTH CENTER PARTNERS OF SOUTHERN CALIFORNIA | 33 | 2018–2026 |
| NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE | 31 | 2017–2025 |
| AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS | 30 | 2017–2024 |
| AMERICAN COLLEGE OF LIFESTYLE MEDICINE | 29 | 2019–2026 |
| VISION SERVICE PLAN | 29 | 2011–2017 |
| REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS | 28 | 2020–2026 |
| KIDNEY CARE COUNCIL | 27 | 2011–2017 |
| NATIONAL ELECTRICAL MANUFACTURERS ASSOCIATION | 27 | 2012–2018 |
| FRESENIUS MEDICAL CARE | 25 | 2011–2017 |
| PREMIER, INC. | 25 | 2013–2019 |
| EYECARE PARTNERS LLC | 24 | 2020–2025 |
| GREATER NEW YORK HOSPITAL ASSOCIATION | 24 | 2013–2019 |
| USAGAINSTALZHEIMER'S ACTION | 23 | 2021–2026 |
| DEVOTED HEALTH | 22 | 2020–2025 |
| ALMOST FAMILY | 21 | 2011–2015 |
| SCAN HEALTH PLAN | 21 | 2012–2017 |
| MARYLAND+COALITION | 19 | 2018–2023 |
| LEADINGAGE, INC. | 18 | 2015–2019 |
| FUTURE OF PHARMACY COALITION LLC | 17 | 2022–2026 |
| BALSAM BRANDS, INC. | 16 | 2019–2026 |
| HEALTHWAYS | 15 | 2015–2018 |
| SUMMA HEALTH | 15 | 2023–2026 |
| CELGENE CORPORATION | 14 | 2012–2015 |
| FLOW THERAPY | 12 | 2019–2022 |
| IOWA DONOR NETWORK | 12 | 2021–2024 |
| IOWA HOSPITAL ASSOCIATION | 12 | 2020–2022 |
| ROHO GROUP | 12 | 2011–2013 |
| THE NRP GROUP LLC | 12 | 2020–2022 |
| EMPLOYEE-OWNED S-CORPORATION OF AMERICA ("ESCA") | 11 | 2012–2014 |
| SELECT MEDICAL CORPORATION | 11 | 2011–2013 |
| ALABAMA HOSPITAL ASSOCIATION | 10 | 2022–2024 |
| AMERICAN AMBULANCE ASSOCIATION | 10 | 2022–2024 |
| AMERICAN HEALTH QUALITY ASSOCIATION | 10 | 2012–2014 |
| COHERUS BIOSCIENCES, INC | 10 | 2022–2024 |
| GOLDMAN SACHS GROUP, INC. | 10 | 2014–2015 |
| UNITED NETWORK FOR ORGAN SHARING (UNOS) | 10 | 2023–2024 |
| INTERPUBLIC GROUP | 9 | 2023–2025 |
| MOHAWK INDUSTRIES INC | 9 | 2021–2026 |
| QLARANT (FORMERLY QUALITY HEALTH STRATEGIES INC ) | 9 | 2017–2018 |
| ULTRASOUND ACCESS COALITION (UAC) (INFORMAL COALITION) | 9 | 2018–2019 |
| VIBRA HEALTHCARE | 9 | 2011–2012 |
| AMERICAN ASSOCIATION OF NURSE ANESTHETISTS | 8 | 2010–2016 |
| BOSTON SCIENTIFIC CORPORATION | 8 | 2025–2026 |
| EMD SERONO, INC. | 8 | 2011–2013 |
| HEALTH REPUBLIC INSURANCE OF NEW YORK | 8 | 2014–2015 |
| PRIMARY CARE ASSOCIATION (INFORMAL COALITION) | 8 | 2025–2026 |
| SOCIETY OF INTERVENTIONAL RADIOLOGY | 8 | 2014–2024 |
| THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH | 8 | 2025–2026 |
| TRISALUS LIFE SCIENCES | 8 | 2022–2024 |
| ACADEMY OF GENERAL DENTISTRY | 7 | 2023–2024 |
| ATHENAHEALTH | 7 | 2011–2012 |
| CHESAPEAKE REGIONAL INFORMATION SYSTEM FOR OUR PATIENTS (CRISP) | 7 | 2021–2022 |
| PERFORMANCE HEALTH | 7 | 2025–2026 |
| PRUITTHEALTH PREMIER | 6 | 2020–2021 |
| AIRPORT SHOPPES CORP | 5 | 2012–2013 |
| ALLIANCE FOR QUALITY NURSING HOME CARE | 5 | 2011–2012 |
| AMERICAN BENEFITS COUNCIL | 5 | 2021–2022 |
| BROOKDALE SENIOR LIVING INC. | 5 | 2020 |
| CETERO RESEARCH | 5 | 2011–2012 |
| CONFLUENT HEALTH | 5 | 2025 |
| EYECARE COALITION (INFORMAL COALITION) | 5 | 2020–2021 |
| MEDICAL MUTUAL OF OHIO | 5 | 2011–2012 |
| OUTSET MEDICAL | 5 | 2023 |
| PROVIDER PARTNERS MANAGEMENT SERVICES, LLC | 5 | 2021–2022 |
| VENN STRATEGIES, LLC, ON BEHALF OF HERFF JONES | 5 | 2014–2015 |
| ACCESS TO PART B SERVICES FOR LTC RESIDENTS COALITION (INFORMAL COALITION) | 4 | 2024 |
| INMAR | 4 | 2020 |
| CVS CAREMARK INC (FORMERLY CAREMARK RX INC ) | 3 | 2011–2012 |
| NATIONAL COORDINATING COMMITTEE FOR MULTIEMPLOYER PLANS | 3 | 2018 |
| ONCOSEC MEDICAL INCORPORATED | 3 | 2020 |
| WANHUA CHEMICAL (AMERICA) CO., LTD. | 3 | 2019–2020 |
| AGENDIA, INC. | 2 | 2026 |
| BIOMERIEUX, INC. | 2 | 2026 |
| CONNOLLY, LLC | 2 | 2013 |
| IMPULSE DYNAMICS USA | 2 | 2026 |
| PARTNERSHIP FOR QUALITY HOME HEALTHCARE | 2 | 2017 |
| RENEWABLE ENERGY GROUP | 2 | 2011 |
| TEMPUS LABS INC | 2 | 2023 |
| THE CAPITAL GROUP COMPANIES, INC. AND ITS AFFILIATES | 2 | 2025 |
| DERMATOLOGY COALITION (INFORMAL COALITION) | 1 | 2026 |
H.R.10571, Surge to Save Newborns Act.
Improve and Enhance the Work Opportunity Tax Credit Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Improve and Enhance the Work Opportunity Tax Credit Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Improve and Enhance the Work Opportunity Tax Credit Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Improve and Enhance the Work Opportunity Tax Credit Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Mikaela Naylon Give Kids a Chance Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Legislation regarding clinical research for rare diseases and orphan drug development, and the Accelerated Approval pathway. H.R.1262/S.932, Give Kids a Chance Act to renew PRV program. Related provisions in Pub. L. No. 119-21, One Big Beautiful Bill Act. The Newborn Screening Reauthorization Act. Importance of patient voice in rare kidney disease.
H.R.1414, Camerons Law, to restore the amount of the Orphan Drug Tax Credit.
H.R.1414, Camerons Law, to restore the amount of the Orphan Drug Tax Credit. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
H.R.1414, Camerons Law, to restore the amount of the Orphan Drug Tax Credit.
New Era of Preventing End-Stage Kidney Disease Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Support of reauthorization of priority review voucher program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
New Era of Preventing End-Stage Kidney Disease Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. H.R.10571, Surge to Save Newborns Act. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Support of reauthorization of priority review voucher program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
New Era of Preventing End-Stage Kidney Disease Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Support of reauthorization of priority review voucher program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
New Era of Preventing End-Stage Kidney Disease Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs, Medicare and Medicaid.
New Era of Preventing End-Stage Kidney Disease Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs, Medicare and Medicaid.
New Era of Preventing End-Stage Kidney Disease Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs, Medicare and Medicaid.
Ensuring Community Access to Pharmacist Services Act
Client: FUTURE OF PHARMACY COALITION LLC · Firm: ALSTON & BIRD LLP
H.R.3164/S.2426, Advance the Ensuring Access to Pharmacist Services Act.
Ensuring Community Access to Pharmacist Services Act
Client: BIOMERIEUX, INC. · Firm: ALSTON & BIRD LLP
Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
Ensuring Community Access to Pharmacist Services Act
Client: FUTURE OF PHARMACY COALITION LLC · Firm: ALSTON & BIRD LLP
H.R.3164/S.2426, Advance the Ensuring Access to Pharmacist Services Act.
Ensuring Community Access to Pharmacist Services Act
Client: BIOMERIEUX, INC. · Firm: ALSTON & BIRD LLP
Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
Travel Trailer and Camper Tax Parity Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Travel Trailer and Camper Tax Parity Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Travel Trailer and Camper Tax Parity Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Travel Trailer and Camper Tax Parity Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. General provisions to address Medicare physician fee schedule payment policies and access to physician services. In general, policies impacting physician burden and sustaining the private practice physician model. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicare physicians payment increase, reform. H.R.9693, Patients First Act. H.R.8163/S.5180, Provider Reimbursement Stability Act. H.R.8375/S.4384, Medicare Advantage Improvement Act.
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.5509/S.2903, The Safe Step Act. Issues related to coverage of products under drug formulary. In general, policies reforming prior authorization of physician services. In general, policies impacting physician burden and sustaining the private practice physician model. Center for Consumer Information and Insurance Oversight guidance on ACA preventive services and coverage of surveillance colonoscopy. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Screening concerns per younger incidence colorectal cancer.
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.5509/S.2903, The Safe Step Act. Issues related to coverage of products under drug formulary. In general, policies reforming prior authorization of physician services. In general, policies impacting physician burden and sustaining the private practice physician model. Center for Consumer Information and Insurance Oversight guidance on ACA preventive services and coverage of surveillance colonoscopy. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Screening concerns per younger incidence colorectal cancer.
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. General provisions to address Medicare physician fee schedule payment policies and access to physician services. In general, policies impacting physician burden and sustaining the private practice physician model. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicare physicians payment increase, reform.
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.5509/S.2903, The Safe Step Act. Issues related to coverage of products under drug formulary. In general, policies reforming prior authorization of physician services. In general, policies impacting physician burden and sustaining the private practice physician model. Center for Consumer Information and Insurance Oversight guidance on ACA preventive services and coverage of surveillance colonoscopy. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Screening concerns per younger incidence colorectal cancer. Office of Management and Budget's Proposed Rule on Uniform Guidance/Uniform Grants Regulation.
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. General provisions to address Medicare physician fee schedule payment policies and access to physician services. In general, policies impacting physician burden and sustaining the private practice physician model. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicare physicians payment increase, reform.
H.R.5509/S.2903, The Safe Step Act. Issues related to coverage of products under drug formulary. In general, policies reforming prior authorization of physician services. In general, policies impacting physician burden and sustaining the private practice physician model. Center for Consumer Information and Insurance Oversight guidance on ACA preventive services and coverage of surveillance colonoscopy. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Screening concerns per younger incidence colorectal cancer.
H.R.5509/S.2903, The Safe Step Act. Issues related to coverage of products under drug formulary. In general, policies reforming prior authorization of physician services. In general, policies impacting physician burden and sustaining the private practice physician model. Center for Consumer Information and Insurance Oversight guidance on ACA preventive services and coverage of surveillance colonoscopy. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Screening concerns per younger incidence colorectal cancer. Office of Management and Budget's Proposed Rule on Uniform Guidance/Uniform Grants Regulation.
H.R.5509/S.2903, The Safe Step Act. Issues related to coverage of products under drug formulary. In general, policies reforming prior authorization of physician services. In general, policies impacting physician burden and sustaining the private practice physician model. Center for Consumer Information and Insurance Oversight guidance on ACA preventive services and coverage of surveillance colonoscopy. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Screening concerns per younger incidence colorectal cancer.
Main Street Tax Certainty Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Main Street Tax Certainty Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Main Street Tax Certainty Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Main Street Tax Certainty Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Provider Reimbursement Stability Act of 2026
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. General provisions to address Medicare physician fee schedule payment policies and access to physician services. In general, policies impacting physician burden and sustaining the private practice physician model. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicare physicians payment increase, reform. H.R.9693, Patients First Act. H.R.8163/S.5180, Provider Reimbursement Stability Act. H.R.8375/S.4384, Medicare Advantage Improvement Act.
Medicare Advantage Improvement Act of 2026
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. General provisions to address Medicare physician fee schedule payment policies and access to physician services. In general, policies impacting physician burden and sustaining the private practice physician model. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicare physicians payment increase, reform. H.R.9693, Patients First Act. H.R.8163/S.5180, Provider Reimbursement Stability Act. H.R.8375/S.4384, Medicare Advantage Improvement Act.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. General provisions to address Medicare physician fee schedule payment policies and access to physician services. In general, policies impacting physician burden and sustaining the private practice physician model. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicare physicians payment increase, reform.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. General provisions to address Medicare physician fee schedule payment policies and access to physician services. In general, policies impacting physician burden and sustaining the private practice physician model. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicare physicians payment increase, reform.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. General provisions to address Medicare physician fee schedule payment policies and access to physician services. In general, policies impacting physician burden and sustaining the private practice physician model. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicare physicians payment increase, reform. H.R.9693, Patients First Act. H.R.8163/S.5180, Provider Reimbursement Stability Act. H.R.8375/S.4384, Medicare Advantage Improvement Act.
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. H.R.10571, Surge to Save Newborns Act. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Support of reauthorization of priority review voucher program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Support of reauthorization of priority review voucher program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Support of reauthorization of priority review voucher program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
Patients First Act of 2026
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. General provisions to address Medicare physician fee schedule payment policies and access to physician services. In general, policies impacting physician burden and sustaining the private practice physician model. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicare physicians payment increase, reform. H.R.9693, Patients First Act. H.R.8163/S.5180, Provider Reimbursement Stability Act. H.R.8375/S.4384, Medicare Advantage Improvement Act.
Travel Trailer and Camper Tax Parity Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Travel Trailer and Camper Tax Parity Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Travel Trailer and Camper Tax Parity Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Travel Trailer and Camper Tax Parity Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. General provisions to address Medicare physician fee schedule payment policies and access to physician services. In general, policies impacting physician burden and sustaining the private practice physician model. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicare physicians payment increase, reform.
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. General provisions to address Medicare physician fee schedule payment policies and access to physician services. In general, policies impacting physician burden and sustaining the private practice physician model. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicare physicians payment increase, reform. H.R.9693, Patients First Act. H.R.8163/S.5180, Provider Reimbursement Stability Act. H.R.8375/S.4384, Medicare Advantage Improvement Act.
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.5509/S.2903, The Safe Step Act. Issues related to coverage of products under drug formulary. In general, policies reforming prior authorization of physician services. In general, policies impacting physician burden and sustaining the private practice physician model. Center for Consumer Information and Insurance Oversight guidance on ACA preventive services and coverage of surveillance colonoscopy. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Screening concerns per younger incidence colorectal cancer. Office of Management and Budget's Proposed Rule on Uniform Guidance/Uniform Grants Regulation.
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.5509/S.2903, The Safe Step Act. Issues related to coverage of products under drug formulary. In general, policies reforming prior authorization of physician services. In general, policies impacting physician burden and sustaining the private practice physician model. Center for Consumer Information and Insurance Oversight guidance on ACA preventive services and coverage of surveillance colonoscopy. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Screening concerns per younger incidence colorectal cancer.
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. General provisions to address Medicare physician fee schedule payment policies and access to physician services. In general, policies impacting physician burden and sustaining the private practice physician model. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicare physicians payment increase, reform.
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.5509/S.2903, The Safe Step Act. Issues related to coverage of products under drug formulary. In general, policies reforming prior authorization of physician services. In general, policies impacting physician burden and sustaining the private practice physician model. Center for Consumer Information and Insurance Oversight guidance on ACA preventive services and coverage of surveillance colonoscopy. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Screening concerns per younger incidence colorectal cancer.
Equitable Community Access to Pharmacist Services Act
Client: FUTURE OF PHARMACY COALITION LLC · Firm: ALSTON & BIRD LLP
H.R.3164/S.2426, Advance the Ensuring Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: BIOMERIEUX, INC. · Firm: ALSTON & BIRD LLP
Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: FUTURE OF PHARMACY COALITION LLC · Firm: ALSTON & BIRD LLP
H.R.3164/S.2426, Advance the Ensuring Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: BIOMERIEUX, INC. · Firm: ALSTON & BIRD LLP
Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
H.R.5509/S.2903, The Safe Step Act. Issues related to coverage of products under drug formulary. In general, policies reforming prior authorization of physician services. In general, policies impacting physician burden and sustaining the private practice physician model. Center for Consumer Information and Insurance Oversight guidance on ACA preventive services and coverage of surveillance colonoscopy. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Screening concerns per younger incidence colorectal cancer.
H.R.5509/S.2903, The Safe Step Act. Issues related to coverage of products under drug formulary. In general, policies reforming prior authorization of physician services. In general, policies impacting physician burden and sustaining the private practice physician model. Center for Consumer Information and Insurance Oversight guidance on ACA preventive services and coverage of surveillance colonoscopy. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Screening concerns per younger incidence colorectal cancer. Office of Management and Budget's Proposed Rule on Uniform Guidance/Uniform Grants Regulation.
H.R.5509/S.2903, The Safe Step Act. Issues related to coverage of products under drug formulary. In general, policies reforming prior authorization of physician services. In general, policies impacting physician burden and sustaining the private practice physician model. Center for Consumer Information and Insurance Oversight guidance on ACA preventive services and coverage of surveillance colonoscopy. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Screening concerns per younger incidence colorectal cancer.
Medicare Advantage Improvement Act of 2026
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. General provisions to address Medicare physician fee schedule payment policies and access to physician services. In general, policies impacting physician burden and sustaining the private practice physician model. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicare physicians payment increase, reform. H.R.9693, Patients First Act. H.R.8163/S.5180, Provider Reimbursement Stability Act. H.R.8375/S.4384, Medicare Advantage Improvement Act.
Improve and Enhance the Work Opportunity Tax Credit Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Improve and Enhance the Work Opportunity Tax Credit Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Improve and Enhance the Work Opportunity Tax Credit Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Improve and Enhance the Work Opportunity Tax Credit Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Provider Reimbursement Stability Act of 2026
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. General provisions to address Medicare physician fee schedule payment policies and access to physician services. In general, policies impacting physician burden and sustaining the private practice physician model. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicare physicians payment increase, reform. H.R.9693, Patients First Act. H.R.8163/S.5180, Provider Reimbursement Stability Act. H.R.8375/S.4384, Medicare Advantage Improvement Act.
Legislation regarding clinical research for rare diseases and orphan drug development, and the Accelerated Approval pathway. H.R.1262/S.932, Give Kids a Chance Act to renew PRV program. Related provisions in Pub. L. No. 119-21, One Big Beautiful Bill Act. The Newborn Screening Reauthorization Act. Importance of patient voice in rare kidney disease.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients. Support of reauthorization of priority review voucher program. H.R.1, One Big Beautiful Bill Act, provisions regarding orphan drugs.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. General provisions to address Medicare physician fee schedule payment policies and access to physician services. In general, policies impacting physician burden and sustaining the private practice physician model. Improving seniors timely access to care. H.R.1, One Big Beautiful Bill Act, provisions regarding Medicare physicians payment increase, reform.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation impacting products approved under the Accelerated Approval pathway. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients. H.R.1, One Big Beautiful Bill Act, provisions regarding orphan drugs.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
H.R.1414, Camerons Law, to restore the amount of the Orphan Drug Tax Credit. Legislation to improve education and care pathways for patients with rare kidney disease. H.R.1, One Big Beautiful Bill Act, provisions regarding orphan drugs.
Improve and Enhance the Work Opportunity Tax Credit Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703/S.213, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Improve and Enhance the Work Opportunity Tax Credit Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703/S.213, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Improve and Enhance the Work Opportunity Tax Credit Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Improve and Enhance the Work Opportunity Tax Credit Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703/S.213, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Mikaela Naylon Give Kids a Chance Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Legislation regarding clinical research for rare diseases and orphan drug development, and the Accelerated Approval pathway. H.R.1262/S.932, Give Kids a Chance Act to renew PRV program. Related provisions in Pub. L. No. 119-21, One Big Beautiful Bill Act. The Newborn Screening Reauthorization Act.
Mikaela Naylon Give Kids a Chance Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Legislation regarding clinical research for rare diseases and orphan drug development, and the Accelerated Approval pathway. H.R.1262/S.932, Give Kids a Chance Act to renew PRV program. Related provisions in Pub. L. No. 119-21, One Big Beautiful Bill Act. The Newborn Screening Reauthorization Act.
H.R.1414, Camerons Law, to restore the amount of the Orphan Drug Tax Credit. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
H.R.1414, Camerons Law, to restore the amount of the Orphan Drug Tax Credit. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
H.R.1414, Camerons Law, to restore the amount of the Orphan Drug Tax Credit. Legislation to improve education and care pathways for patients with rare kidney disease. H.R.1, One Big Beautiful Bill Act, provisions regarding orphan drugs.
H.R.1414, Camerons Law, to restore the amount of the Orphan Drug Tax Credit. Legislation to improve education and care pathways for patients with rare kidney disease.
H.R.1414, Camerons Law, to restore the amount of the Orphan Drug Tax Credit. Legislation to improve education and care pathways for patients with rare kidney disease.
New Era of Preventing End-Stage Kidney Disease Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients. Support of reauthorization of priority review voucher program. H.R.1, One Big Beautiful Bill Act, provisions regarding orphan drugs.
New Era of Preventing End-Stage Kidney Disease Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation impacting products approved under the Accelerated Approval pathway. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients. H.R.1, One Big Beautiful Bill Act, provisions regarding orphan drugs.
New Era of Preventing End-Stage Kidney Disease Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients. Support of reauthorization of priority review voucher program. H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025.
New Era of Preventing End-Stage Kidney Disease Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation impacting products approved under the Accelerated Approval pathway. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients.
New Era of Preventing End-Stage Kidney Disease Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients. Support of reauthorization of priority review voucher program. H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025.
New Era of Preventing End-Stage Kidney Disease Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation impacting products approved under the Accelerated Approval pathway. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients.
New Era of Preventing End-Stage Kidney Disease Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Support of reauthorization of priority review voucher program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
New Era of Preventing End-Stage Kidney Disease Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs, Medicare and Medicaid.
New Era of Preventing End-Stage Kidney Disease Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs, Medicare and Medicaid.
New Era of Preventing End-Stage Kidney Disease Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Support of reauthorization of priority review voucher program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. General provisions to address Medicare physician fee schedule payment policies and access to physician services. In general, policies impacting physician burden and sustaining the private practice physician model. Improving seniors timely access to care. H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025.
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
Funding for colorectal cancer screening and education. In general, policies impacting physician burden and sustaining the private practice physician model. H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025.
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients. Support of reauthorization of priority review voucher program. H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025.
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients. Support of reauthorization of priority review voucher program. H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025.
Travel Trailer and Camper Tax Parity Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Issues related to funding for Alzheimer's research, engaging with key lawmakers and agency officials in defense of NIH spending overall.
Issues related to funding for Alzheimer's research, engaging with key lawmakers and agency officials in defense of NIH spending overall.
Issues related to funding for Alzheimer's research, engaging with key lawmakers and agency officials in defense of NIH spending overall.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TRAVERE THERAPEUTICS via ALSTON & BIRD LLP
2026 · third_quarter · Q3
H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs, Medicare and Medicaid.
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. H.R.10571, Surge to Save Newborns Act. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Support of reauthorization of priority review voucher program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
H.R.1414, Camerons Law, to restore the amount of the Orphan Drug Tax Credit.
H.R.10571, Surge to Save Newborns Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Advancing research to find a cure for Parkinson's disease.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SUMMA HEALTH via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Medicare payment issues impacting hospitals. Medicare Advantage issues.
Medicare payment issues impacting hospitals. Medicare Advantage issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PRIMARY CARE ASSOCIATION (INFORMAL COALITION) via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Funding for community health center programs. Medicaid funding.
Funding for community health center programs. Medicaid funding.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE
PERFORMANCE HEALTH via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Tariffs on products Performance Health imports from China and other countries.
Tariffs on products Performance Health imports from China and other countries.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
MOHAWK INDUSTRIES, INC. via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Trade matters affecting the flooring and construction industry.
2026 · third_quarter · Q3
Affordable Care Act Health Reform; Implementation of Health Reform; Medicare/Medicaid Reimbursement; Cost plan matters; Medicare Cost Plan and Reimbursement.
Affordable Care Act Health Reform; Implementation of Health Reform; Medicare/Medicaid Reimbursement; Cost plan matters; Medicare Cost Plan and Reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
IMPULSE DYNAMICS USA via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Medicare reimbursement for medical device.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
HEALTH CENTER PARTNERS OF SOUTHERN CALIFORNIA via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Issues related to Teaching Health Center GME, Community Health Center funding, and Telehealth.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FUTURE OF PHARMACY COALITION LLC via ALSTON & BIRD LLP
2026 · third_quarter · Q3
H.R.3164/S.2426, Advance the Ensuring Access to Pharmacist Services Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CVS HEALTH via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Issues related to Pub. L. No. 119-21, One Big Beautiful Bill Act, PBM reform and drug pricing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
BOSTON SCIENTIFIC CORPORATION via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Issues concerning Medicare reimbursement, AI and medical technology.
Advocacy concerning tax issues.
Advocacy concerning trade issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOMERIEUX, INC. via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BALSAM BRANDS, INC. via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Issues related to tariffs and other trade actions affecting small and midsize businesses.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office
AMERICAN COLLEGE OF GASTROENTEROLOGY via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Funding for colorectal cancer screening and education. In general, policies impacting physician burden and sustaining the private practice physician model. Center for Consumer Information and Insurance Oversight guidance on ACA preventive services and coverage of surveillance colonoscopy. Screening concerns per younger incidence colorectal cancer. Office of Management and Budget's Proposed Rule on Uniform Guidance/Uniform Grants Regulation.
H.R.5509/S.2903, The Safe Step Act. Issues related to coverage of products under drug formulary. In general, policies reforming prior authorization of physician services. In general, policies impacting physician burden and sustaining the private practice physician model. Center for Consumer Information and Insurance Oversight guidance on ACA preventive services and coverage of surveillance colonoscopy. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Screening concerns per younger incidence colorectal cancer. Office of Management and Budget's Proposed Rule on Uniform Guidance/Uniform Grants Regulation.
DERMATOLOGY COALITION (INFORMAL COALITION) via ALSTON & BIRD LLP
2026 · third_quarter · RR
Medicare payment issues.
USAGAINSTALZHEIMER'S ACTION via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Issues related to funding for Alzheimer's research, engaging with key lawmakers and agency officials in defense of NIH spending overall.
Issues related to funding for Alzheimer's research, engaging with key lawmakers and agency officials in defense of NIH spending overall.
Issues related to funding for Alzheimer's research, engaging with key lawmakers and agency officials in defense of NIH spending overall.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TRAVERE THERAPEUTICS via ALSTON & BIRD LLP
2026 · second_quarter · Q2
The Newborn Screening Reauthorization Act, and improving funding of newborn screening implementation; Importance of patient voice in rare kidney disease.
H.R.1414, Camerons Law, to restore the amount of the Orphan Drug Tax Credit.
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Support of reauthorization of priority review voucher program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Advancing research to find a cure for Parkinson's disease.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SUMMA HEALTH via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Medicare payment issues impacting hospitals. Medicare Advantage issues.
Medicare payment issues impacting hospitals. Medicare Advantage issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOMERIEUX, INC. via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF GASTROENTEROLOGY via ALSTON & BIRD LLP
2026 · second_quarter · Q2
H.R.5509/S.2903, The Safe Step Act. Issues related to coverage of products under drug formulary. In general, policies reforming prior authorization of physician services. In general, policies impacting physician burden and sustaining the private practice physician model. Center for Consumer Information and Insurance Oversight guidance on ACA preventive services and coverage of surveillance colonoscopy. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Screening concerns per younger incidence colorectal cancer.
H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. General provisions to address Medicare physician fee schedule payment policies and access to physician services. In general, policies impacting physician burden and sustaining the private practice physician model. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicare physicians payment increase, reform.
REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PRIMARY CARE ASSOCIATION (INFORMAL COALITION) via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Funding for community health center programs. Medicaid funding.
Funding for community health center programs. Medicaid funding.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE
PERFORMANCE HEALTH via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Tariffs on products Performance Health imports from China and other countries.
Tariffs on products Performance Health imports from China and other countries.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
MOHAWK INDUSTRIES, INC. via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Trade matters affecting the flooring and construction industry.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office
2026 · second_quarter · Q2
Affordable Care Act Health Reform; Implementation of Health Reform; Medicare/Medicaid Reimbursement; Cost plan matters; Medicare Cost Plan and Reimbursement.
Affordable Care Act Health Reform; Implementation of Health Reform; Medicare/Medicaid Reimbursement; Cost plan matters; Medicare Cost Plan and Reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HEALTH CENTER PARTNERS OF SOUTHERN CALIFORNIA via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Issues related to Teaching Health Center GME, Community Health Center funding, and Telehealth.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FUTURE OF PHARMACY COALITION LLC via ALSTON & BIRD LLP
2026 · second_quarter · Q2
H.R.3164/S.2426, Advance the Ensuring Access to Pharmacist Services Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CVS HEALTH via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Issues related to Pub. L. No. 119-21, One Big Beautiful Bill Act, PBM reform and drug pricing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
BOSTON SCIENTIFIC CORPORATION via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Advocacy concerning tax issues.
Issues concerning Medicare reimbursement, AI and medical technology.
Advocacy concerning trade issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BALSAM BRANDS, INC. via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Issues related to tariffs and other trade actions affecting small and midsize businesses.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office
AGENDIA, INC. via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Issues related to Medicare coverage.
Issues related to Medicare coverage.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
IMPULSE DYNAMICS USA via ALSTON & BIRD LLP
2026 · second_quarter · RR
Medicare reimbursement issues.
MOHAWK INDUSTRIES, INC. via ALSTON & BIRD LLP
2026 · first_quarter · 1A
Trade matters affecting the flooring and construction industry.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office
USAGAINSTALZHEIMER'S ACTION via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Issues related to funding for Alzheimer's research, engaging with key lawmakers and agency officials in defense of NIH spending overall.
Issues related to funding for Alzheimer's research, engaging with key lawmakers and agency officials in defense of NIH spending overall.
Issues related to funding for Alzheimer's research, engaging with key lawmakers and agency officials in defense of NIH spending overall.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TRAVERE THERAPEUTICS via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Support of reauthorization of priority review voucher program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
Legislation regarding clinical research for rare diseases and orphan drug development, and the Accelerated Approval pathway. H.R.1262/S.932, Give Kids a Chance Act to renew PRV program. Related provisions in Pub. L. No. 119-21, One Big Beautiful Bill Act. The Newborn Screening Reauthorization Act. Importance of patient voice in rare kidney disease.
THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Advancing research to find a cure for Parkinson's disease.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SUMMA HEALTH via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Medicare payment issues impacting hospitals. Medicare Advantage issues.
Medicare payment issues impacting hospitals. Medicare Advantage issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PRIMARY CARE ASSOCIATION (INFORMAL COALITION) via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Funding for community health center programs. Medicaid funding.
Funding for community health center programs. Medicaid funding.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE
PERFORMANCE HEALTH via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Tariffs on products Performance Health imports from China and other countries.
Tariffs on products Performance Health imports from China and other countries.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
MOHAWK INDUSTRIES, INC. via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Trade matters affecting the flooring and construction industry.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office
2026 · first_quarter · Q1
Affordable Care Act Health Reform; Implementation of Health Reform; Medicare/Medicaid Reimbursement; Cost plan matters; Medicare Cost Plan and Reimbursement.
Affordable Care Act Health Reform; Implementation of Health Reform; Medicare/Medicaid Reimbursement; Cost plan matters; Medicare Cost Plan and Reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HEALTH CENTER PARTNERS OF SOUTHERN CALIFORNIA via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Issues related to Teaching Health Center GME, Community Health Center funding, Telehealth and Covid related issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FUTURE OF PHARMACY COALITION LLC via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Advance the Ensuring Access to Pharmacist Services Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF GASTROENTEROLOGY via ALSTON & BIRD LLP
2026 · first_quarter · Q1
H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. General provisions to address Medicare physician fee schedule payment policies and access to physician services. In general, policies impacting physician burden and sustaining the private practice physician model. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicare physicians payment increase, reform.
Funding for colorectal cancer screening and education. In general, policies impacting physician burden and sustaining the private practice physician model. Center for Consumer Information and Insurance Oversight guidance on ACA preventive services and coverage of surveillance colonoscopy. Screening concerns per younger incidence colorectal cancer.
CVS HEALTH via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Issues related to Pub. L. No. 119-21, One Big Beautiful Bill Act, PBM reform and drug pricing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
BOSTON SCIENTIFIC CORPORATION via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Issues concerning Medicare reimbursement, AI and medical technology.
Advocacy concerning trade issues.
Advocacy concerning tax issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BALSAM BRANDS, INC. via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Issues related to tariffs and other trade actions affecting small and midsize businesses.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office
AGENDIA, INC. via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Issues related to Medicare coverage.
Issues related to Medicare coverage.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN COLLEGE OF LIFESTYLE MEDICINE via ALSTON & BIRD LLP
2026 · first_quarter · 1T
Issues related to Food as Medicine and Make America Healthy Again agenda.
Issues related to Food as Medicine and Make America Healthy Again agenda.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TRAVERE THERAPEUTICS via ALSTON & BIRD LLP
2025 · first_quarter · 1A
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients. Support of reauthorization of priority review voucher program. H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025.
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation impacting products approved under the Accelerated Approval pathway. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients.
USAGAINSTALZHEIMER'S ACTION via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Issues related to funding for Alzheimer's research, engaging with key lawmakers and agency officials in defense of NIH spending overall.
Issues related to funding for Alzheimer's research, engaging with key lawmakers and agency officials in defense of NIH spending overall.
Issues related to funding for Alzheimer's research, engaging with key lawmakers and agency officials in defense of NIH spending overall.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TRAVERE THERAPEUTICS via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
H.R.1414, Camerons Law, to restore the amount of the Orphan Drug Tax Credit. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs, Medicare and Medicaid.
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Support of reauthorization of priority review voucher program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Advancing research to find a cure for Parkinson's disease.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SUMMA HEALTH via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Medicare payment issues impacting hospitals. Medicare Advantage issues.
Medicare payment issues impacting hospitals. Medicare Advantage issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PRIMARY CARE ASSOCIATION (INFORMAL COALITION) via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Funding for community health center programs. Medicaid funding.
Funding for community health center programs. Medicaid funding.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE
PERFORMANCE HEALTH via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Tariffs on products Performance Health imports from China and other countries.
Tariffs on products Performance Health imports from China and other countries.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
MOHAWK INDUSTRIES, INC. via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Trade matters affecting the flooring and construction industry.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office
2025 · fourth_quarter · Q4
Affordable Care Act Health Reform; Implementation of Health Reform; Medicare/Medicaid Reimbursement; Cost plan matters; Medicare Cost Plan and Reimbursement.
Affordable Care Act Health Reform; Implementation of Health Reform; Medicare/Medicaid Reimbursement; Cost plan matters; Medicare Cost Plan and Reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INTERPUBLIC GROUP via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Comprehensive federal data privacy legislation.
Comprehensive federal data privacy legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTH CENTER PARTNERS OF SOUTHERN CALIFORNIA via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Issues related to Teaching Health Center GME, Community Health Center funding, Telehealth and Covid related issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FUTURE OF PHARMACY COALITION LLC via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Advance the Ensuring Access to Pharmacist Services Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EYECARE PARTNERS LLC via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Reimbursement issues for eye care industry.
Reimbursement issues for eye care industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CVS HEALTH via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Issues related to Pub. L. No. 119-21, One Big Beautiful Bill Act, PBM reform and drug pricing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
CONFLUENT HEALTH via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Physician payment issues.
Physician payment issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOSTON SCIENTIFIC CORPORATION via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Issues concerning Medicare reimbursement, AI and medical technology.
Advocacy concerning tax issues.
Advocacy concerning trade issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BALSAM BRANDS, INC. via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Issues related to tariffs and other trade actions affecting small and midsize businesses.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office
AMERICAN COLLEGE OF LIFESTYLE MEDICINE via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Issues related to Food as Medicine and Make America Healthy Again agenda.
Issues related to Food as Medicine and Make America Healthy Again agenda.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TRAVERE THERAPEUTICS via ALSTON & BIRD LLP
2025 · third_quarter · Q3
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Support of reauthorization of priority review voucher program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs, Medicare and Medicaid.
USAGAINSTALZHEIMER'S ACTION via ALSTON & BIRD LLP
2025 · third_quarter · Q3
Issues related to funding for Alzheimer's research, engaging with key lawmakers and agency officials in defense of NIH spending overall.
Issues related to funding for Alzheimer's research, engaging with key lawmakers and agency officials in defense of NIH spending overall.
Issues related to funding for Alzheimer's research, engaging with key lawmakers and agency officials in defense of NIH spending overall.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH via ALSTON & BIRD LLP
2025 · third_quarter · Q3
Advancing research to find a cure for Parkinson's disease.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SUMMA HEALTH via ALSTON & BIRD LLP
2025 · third_quarter · Q3
Medicare payment issues impacting hospitals. Medicare Advantage issues.
Medicare payment issues impacting hospitals. Medicare Advantage issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS via ALSTON & BIRD LLP
2025 · third_quarter · Q3
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703/S.213, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PRIMARY CARE ASSOCIATION (INFORMAL COALITION) via ALSTON & BIRD LLP
2025 · third_quarter · Q3
Funding for community health center programs. Medicaid funding.
Funding for community health center programs. Medicaid funding.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE
PERFORMANCE HEALTH via ALSTON & BIRD LLP
2025 · third_quarter · Q3
Tariffs on products Performance Health imports from China and other countries.
Tariffs on products Performance Health imports from China and other countries.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
MOHAWK INDUSTRIES, INC. via ALSTON & BIRD LLP
2025 · third_quarter · Q3
Trade matters affecting the flooring and construction industry.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office
2025 · third_quarter · Q3
Affordable Care Act Health Reform; Implementation of Health Reform; Medicare/Medicaid Reimbursement; Cost plan matters; Medicare Cost Plan and Reimbursement.
Affordable Care Act Health Reform; Implementation of Health Reform; Medicare/Medicaid Reimbursement; Cost plan matters; Medicare Cost Plan and Reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INTERPUBLIC GROUP via ALSTON & BIRD LLP
2025 · third_quarter · Q3
Comprehensive federal data privacy legislation.
Comprehensive federal data privacy legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTH CENTER PARTNERS OF SOUTHERN CALIFORNIA via ALSTON & BIRD LLP
2025 · third_quarter · Q3
Issues related to Teaching Health Center GME, Community Health Center funding, Telehealth and Covid related issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FUTURE OF PHARMACY COALITION LLC via ALSTON & BIRD LLP
2025 · third_quarter · Q3
Advance the Ensuring Access to Pharmacist Services Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EYECARE PARTNERS LLC via ALSTON & BIRD LLP
2025 · third_quarter · Q3
Reimbursement issues for eye care industry.
Reimbursement issues for eye care industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DEVOTED HEALTH via ALSTON & BIRD LLP
2025 · third_quarter · Q3
Issues related to Medicare Advantage Health Plan.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CVS HEALTH via ALSTON & BIRD LLP
2025 · third_quarter · Q3
Issues related to Pub. L. No. 119-21, One Big Beautiful Bill Act, PBM reform and drug pricing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
CONFLUENT HEALTH via ALSTON & BIRD LLP
2025 · third_quarter · Q3
Physician payment issues.
Physician payment issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOSTON SCIENTIFIC CORPORATION via ALSTON & BIRD LLP
2025 · third_quarter · Q3
Issues concerning Medicare reimbursement, AI and medical technology.
Advocacy concerning tax issues.
Advocacy concerning trade issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BALSAM BRANDS, INC. via ALSTON & BIRD LLP
2025 · third_quarter · Q3
Issues related to tariffs and other trade actions affecting small and midsize businesses.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office
AMERICAN COLLEGE OF LIFESTYLE MEDICINE via ALSTON & BIRD LLP
2025 · third_quarter · Q3
Issues related to Food as Medicine and Make America Healthy Again agenda.
Issues related to Food as Medicine and Make America Healthy Again agenda.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN COLLEGE OF GASTROENTEROLOGY via ALSTON & BIRD LLP
2025 · third_quarter · Q3
H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. General provisions to address Medicare physician fee schedule payment policies and access to physician services. In general, policies impacting physician burden and sustaining the private practice physician model. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicare physicians payment increase, reform.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MOHAWK INDUSTRIES, INC. via ALSTON & BIRD LLP
2025 · third_quarter · RA
Trade matters affecting the flooring and construction industry.
USAGAINSTALZHEIMER'S ACTION via ALSTON & BIRD LLP
2025 · second_quarter · Q2
Issues related to increasing funding for Alzheimer's research and improving strategies for early detection and prevention; family and medical leave; Advanced Research Projects Agency-Health (ARPA-H); establishing a national Alzheimer's disease prevention goal.
Issues related to increasing funding for Alzheimer's research and improving strategies for early detection and prevention; family and medical leave; Advanced Research Projects Agency-Health (ARPA-H); establishing a national Alzheimer's disease prevention goal.
Issues related to increasing funding for Alzheimer's research and improving strategies for early detection and prevention; Advanced Research Projects Agency-Health (ARPA-H); establishing a national Alzheimer's disease prevention goal.
TRAVERE THERAPEUTICS via ALSTON & BIRD LLP
2025 · second_quarter · Q2
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients. Support of reauthorization of priority review voucher program. H.R.1, One Big Beautiful Bill Act, provisions regarding orphan drugs.
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation impacting products approved under the Accelerated Approval pathway. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients. H.R.1, One Big Beautiful Bill Act, provisions regarding orphan drugs.
THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH via ALSTON & BIRD LLP
2025 · second_quarter · Q2
Advancing research to find a cure for Parkinson's disease.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SUMMA HEALTH via ALSTON & BIRD LLP
2025 · second_quarter · Q2
Medicare payment issues impacting hospitals. Medicare Advantage issues.
Medicare payment issues impacting hospitals. Medicare Advantage issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. General provisions to address Medicare physician fee schedule payment policies and access to physician services. In general, policies impacting physician burden and sustaining the private practice physician model. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicare physicians payment increase, reform. H.R.9693, Patients First Act. H.R.8163/S.5180, Provider Reimbursement Stability Act. H.R.8375/S.4384, Medicare Advantage Improvement Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs, Medicare and Medicaid.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Funding for colorectal cancer screening and education. In general, policies impacting physician burden and sustaining the private practice physician model. Center for Consumer Information and Insurance Oversight guidance on ACA preventive services and coverage of surveillance colonoscopy. Screening concerns per younger incidence colorectal cancer.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs, Medicare and Medicaid.
H.R.1414, Camerons Law, to restore the amount of the Orphan Drug Tax Credit. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R.5509/S.2903, The Safe Step Act. Issues related to coverage of products under drug formulary. In general, policies reforming prior authorization of physician services. In general, policies impacting physician burden and sustaining the private practice physician model. Center for Consumer Information and Insurance Oversight guidance on ACA preventive services and coverage of surveillance colonoscopy. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Screening concerns per younger incidence colorectal cancer.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
Legislation regarding clinical research for rare diseases and orphan drug development, and the Accelerated Approval pathway. Support of reauthorization of priority review voucher program.
H.R.1414, Camerons Law, to restore the amount of the Orphan Drug Tax Credit. Legislation to improve education and care pathways for patients with rare kidney disease.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Legislation regarding clinical research for rare diseases and orphan drug development, and the Accelerated Approval pathway. H.R.1262/S.932, Give Kids a Chance Act to renew PRV program. Related provisions in Pub. L. No. 119-21, One Big Beautiful Bill Act. The Newborn Screening Reauthorization Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Legislation regarding clinical research for rare diseases and orphan drug development, and the Accelerated Approval pathway. H.R.1262/S.932, Give Kids a Chance Act to renew PRV program. Related provisions in Pub. L. No. 119-21, One Big Beautiful Bill Act. The Newborn Screening Reauthorization Act.
H.R.1414, Camerons Law, to restore the amount of the Orphan Drug Tax Credit. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Legislation regarding clinical research for rare diseases and orphan drug development, and the Accelerated Approval pathway. Support of reauthorization of priority review voucher program.
H.R.1414, Camerons Law, to restore the amount of the Orphan Drug Tax Credit. Legislation to improve education and care pathways for patients with rare kidney disease. H.R.1, One Big Beautiful Bill Act, provisions regarding orphan drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE